PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Public Health Services, Israel Ministry of Health, Jerusalem, Israel; Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva, Israel.\', \'Pfizer, Collegeville, PA, USA.\', \'Public Health Services, Israel Ministry of Health, Jerusalem, Israel; Hadassah Braun School of Public Health, Hebrew University, Jerusalem, Israel.\', \'Information Technology Department, Israel Ministry of Health, Jerusalem, Israel.\', \'Pfizer Pharmaceuticals Israel, Herzliya, Israel.\', \'Israel Ministry of Health, Jerusalem, Israel.\', \'Public Health Services, Israel Ministry of Health, Jerusalem, Israel. Electronic address: sharon.alroy@moh.gov.il.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0140-6736(21)00947-810.1016/S0140-6736(21)00947-8
?:doi
?:hasPublicationType
?:journal
  • Lancet (London, England)
is ?:pmid of
?:pmid
?:pmid
  • 33964222
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33964222>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33964222>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all